lilly oral glp 1 is now pharma's top revenue company. It just got FDA approval for an GLP-1, but Wall Street isn't celebrating Aleniglipron: An Oral, Small Molecule
Description
Quick Answer: GLP-1 receptor agonists improve fatty liver disease by reducing liver fat content, improving liver enzymes, and achieving NASH resolution in clinical trials, primarily through weight loss and enhanced insulin sensitivity

How do I take these medications
Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms
Start physician-guided weight loss from home with secure telehealth available statewide in Florida
This new AI-powered feature brings individual meal recommendations to life by leveraging members food preferences, dietary goals and current meal logs
Accessed April 10, 2026.
